Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2020

Open Access 01-04-2020

Introduction to special section on: current topics in cancer survivorship and work

Published in: Journal of Cancer Survivorship | Issue 2/2020

Login to get access

Abstract

Work is a key contributor to quality of life and an important aspect of cancer survivorship. We call attention to current topics in cancer survivorship and work with 12 articles on cancer survivorship and work in this special section. The focus is on less studied diagnostic groups such as gastrointestinal cancer and prostate cancer, and on long-term effects of cancer diagnosis and treatment on work. Furthermore, studies are included on topics not generally studied including cognitive limitations and pain, the role of the employer on work outcomes among different types of cancer survivors and some countries not typically covered in the existing literature on work and cancer survivorship. We conclude that to improve sustainable work participation in cancer survivors, personalised, tailored interventions should be provided. A prerequisite for this is the identification of groups and individuals at high risk for adverse work outcomes. In order to develop such interventions, research involving new approaches such as matching data registries, participatory approaches and the involvement of many stakeholders and survivors with these different types of cancer diagnoses is necessary.

Implications for Cancer Survivors

The goal of sustainable work participation in cancer survivors can be improved by the delivery of a personalised or risk-based tailored intervention. Furthermore, successful work outcomes often involve many stakeholders who should all be included Implications for Cancer Survivors. The goal of sustainable work participation in cancer survivors can be improved by the delivery of a personalised or risk-based tailored intervention. Furthermore, successful work outcomes often involve many stakeholders who should all be included.
Literature
1.
go back to reference Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.CrossRef Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.CrossRef
2.
go back to reference Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.CrossRef Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.CrossRef
3.
go back to reference De Boer AGEM, Taskila T, Ojajärvi A, van Dijk FJH, Verbeek JHAM. Cancer survivors and unemployment—a meta-analysis and meta-regression. JAMA. 2009;301:753–62.CrossRef De Boer AGEM, Taskila T, Ojajärvi A, van Dijk FJH, Verbeek JHAM. Cancer survivors and unemployment—a meta-analysis and meta-regression. JAMA. 2009;301:753–62.CrossRef
4.
go back to reference Duijts SFA, Kieffer JM, van Muijen P, van der Beek AJ. Sustained employability and health-related quality of life in cancer survivors up to four years after diagnosis. Acta Oncol. 2017;56:174–82.CrossRef Duijts SFA, Kieffer JM, van Muijen P, van der Beek AJ. Sustained employability and health-related quality of life in cancer survivors up to four years after diagnosis. Acta Oncol. 2017;56:174–82.CrossRef
5.
go back to reference Feuerstein M. The Journal of Cancer Survivorship: retrospective and future directions. J Cancer Surviv. 2011;5:315–9.CrossRef Feuerstein M. The Journal of Cancer Survivorship: retrospective and future directions. J Cancer Surviv. 2011;5:315–9.CrossRef
6.
go back to reference Feuerstein M. Optimizing cancer survivorship. J Cancer Surviv. 2007;1:1–4.CrossRef Feuerstein M. Optimizing cancer survivorship. J Cancer Surviv. 2007;1:1–4.CrossRef
7.
go back to reference Seifart U, Schmielau J. Return to work of cancer survivors. Oncol Res Treat. 2017;40:760–3.CrossRef Seifart U, Schmielau J. Return to work of cancer survivors. Oncol Res Treat. 2017;40:760–3.CrossRef
8.
go back to reference Kiasuwa Mbengi R, Otter R, Mortelmans K, Arbyn M, Van Oyen H, Bouland C, et al. Barriers and opportunities for return-to-work of cancer survivors: time for action--rapid review and expert consultation. Syst Rev. 2016;5:35.CrossRef Kiasuwa Mbengi R, Otter R, Mortelmans K, Arbyn M, Van Oyen H, Bouland C, et al. Barriers and opportunities for return-to-work of cancer survivors: time for action--rapid review and expert consultation. Syst Rev. 2016;5:35.CrossRef
9.
go back to reference Greidanus MA, de Boer AGEM, de Rijk AE, Tiedtke CM, Dierckx de Casterlé B, Frings-Dresen MHW, et al. Perceived employer-related barriers and facilitators for work participation of cancer survivors: a systematic review of employers’ and survivors’ perspectives. Psychooncology. 2018;27:725–33.CrossRef Greidanus MA, de Boer AGEM, de Rijk AE, Tiedtke CM, Dierckx de Casterlé B, Frings-Dresen MHW, et al. Perceived employer-related barriers and facilitators for work participation of cancer survivors: a systematic review of employers’ and survivors’ perspectives. Psychooncology. 2018;27:725–33.CrossRef
10.
go back to reference McLennan V, Ludvik D, Chambers S, Frydenberg M. Work after prostate cancer: a systematic review. J Cancer Surviv. 2019;13:282–91.CrossRef McLennan V, Ludvik D, Chambers S, Frydenberg M. Work after prostate cancer: a systematic review. J Cancer Surviv. 2019;13:282–91.CrossRef
11.
go back to reference Zaman AGNM, Tytgat KMAJ, Klinkenbijl JHG, de Boer AGEM, Frings-Dresen MHW. Process evaluation of a tailored work-related support intervention for patients diagnosed with gastrointestinal cancer. J Cancer Surviv. 2020;14:59–71. Zaman AGNM, Tytgat KMAJ, Klinkenbijl JHG, de Boer AGEM, Frings-Dresen MHW. Process evaluation of a tailored work-related support intervention for patients diagnosed with gastrointestinal cancer. J Cancer Surviv. 2020;14:59–71.
14.
go back to reference de Boer AG. The European cancer and work network: CANWON. J Occup Rehabil. 2014;24:393–8.CrossRef de Boer AG. The European cancer and work network: CANWON. J Occup Rehabil. 2014;24:393–8.CrossRef
15.
go back to reference de Boer AGEM, Torp S, Popa A, Horsboel T, Zadnik G, Rotenberg Y, et al. Long-term work retention after treatment for cancer: a systematic review and meta-analysis. J Cancer Surviv. 2020. de Boer AGEM, Torp S, Popa A, Horsboel T, Zadnik G, Rotenberg Y, et al. Long-term work retention after treatment for cancer: a systematic review and meta-analysis. J Cancer Surviv. 2020.
16.
go back to reference Tamminga SJ, Coenen P, Paalman C, de Boer AGEM, Aaronson NK, Oldenburg HSA, et al. Factors associated with an adverse work outcome in breast cancer survivors 5-10 years after diagnosis: a cross-sectional study. J Cancer Surviv. 2019;13:108–16.CrossRef Tamminga SJ, Coenen P, Paalman C, de Boer AGEM, Aaronson NK, Oldenburg HSA, et al. Factors associated with an adverse work outcome in breast cancer survivors 5-10 years after diagnosis: a cross-sectional study. J Cancer Surviv. 2019;13:108–16.CrossRef
22.
23.
go back to reference Feuerstein M, Todd BL, Moskowitz MC, Bruns GL, Stoler MR, Nassif T, et al. Work in cancer survivors: a model for practice and research. J Cancer Surviv. 2010;4:415–37.CrossRef Feuerstein M, Todd BL, Moskowitz MC, Bruns GL, Stoler MR, Nassif T, et al. Work in cancer survivors: a model for practice and research. J Cancer Surviv. 2010;4:415–37.CrossRef
24.
go back to reference Kvillemo P, Mittendorfer-Rutz E, Bränström R, Nilsson K, Alexanderson K. Sickness absence and disability pension after breast cancer diagnosis: a 5-year nationwide cohort study. J Clin Oncol. 2017;35:2044–52.CrossRef Kvillemo P, Mittendorfer-Rutz E, Bränström R, Nilsson K, Alexanderson K. Sickness absence and disability pension after breast cancer diagnosis: a 5-year nationwide cohort study. J Clin Oncol. 2017;35:2044–52.CrossRef
25.
go back to reference Abma T, Banks S, Cook T, Dias S, Madsen W, Springett J, et al. Participatory research for health and social well-being. Switzerland: Springer; 2018. Abma T, Banks S, Cook T, Dias S, Madsen W, Springett J, et al. Participatory research for health and social well-being. Switzerland: Springer; 2018.
26.
go back to reference Bondesson T, Petersson LM, Wennman-Larsen A, Alexanderson K, Kjeldgård L, Nilsson MI. A study to examine the influence of health professionals’ advice and support on work capacity and sick leave after breast cancer surgery. Support Care Cancer. 2016;24:4141–8.CrossRef Bondesson T, Petersson LM, Wennman-Larsen A, Alexanderson K, Kjeldgård L, Nilsson MI. A study to examine the influence of health professionals’ advice and support on work capacity and sick leave after breast cancer surgery. Support Care Cancer. 2016;24:4141–8.CrossRef
Metadata
Title
Introduction to special section on: current topics in cancer survivorship and work
Publication date
01-04-2020
Published in
Journal of Cancer Survivorship / Issue 2/2020
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-020-00868-w

Other articles of this Issue 2/2020

Journal of Cancer Survivorship 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine